02379nam 2200397 450 991067404530332120230624065520.0(CKB)5400000000043534(NjHacI)995400000000043534(EXLCZ)99540000000004353420230624d2022 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierDiagnosis of Endometriosis Biomarkers and Clinical Methods /Antonio Simone LaganàBasel, Switzerland :MDPI - Multidisciplinary Digital Publishing Institute,2022.1 online resource (130 pages) illustrations3-0365-2801-6 Endometriosis is defined as the presence of endometrial-like endometrial cells, glands, and stroma outside the uterus, causing a wide range of symptoms and signs, including acute and chronic pelvic pain and infertility. Endometriosis affects approximately 10% of women of reproductive age, and up to 50% of infertile women. The etiopathogenesis of endometriosis still remains controversial: immune, hormonal, genetic, and epigenetic factors may be all involved, and several theories have been proposed to explain it. One of the main problems for the management of endometriosis is the significant diagnostic delay: to date, several biomarkers are currently being tested in order to provide a reliable non-invasive diagnosis in case of symptoms and signs suspicious for endometriosis. In addition, ultrasound techniques and magnetic resonance imaging are evolving rapidly, allowing for better accuracy, even with the use of artificial intelligence. Finally, new potential histological makers are helping to correlate the occurrence of endometriosis in different anatomical landmarks, supporting specific pathways to clarify the etiology of the disease.Diagnosis of Endometriosis EndometriosisEndometriosisDiagnosisBiomedical engineeringEndometriosis.EndometriosisDiagnosis.Biomedical engineering.618.1Laganà Antonio Simone1367632NjHacINjHaclBOOK9910674045303321Diagnosis of Endometriosis3391249UNINA